Skip to main content
← back
Informative

Truemeds closes $85 Mn Series C round led by Accel and PeakXV

Update / Judgement Date

11 Aug 2025

Source

Entrackr

Author

Team — WCP Legal Desk

Reading Time

1 min read

Corporate Compliance

Truemeds has closed an $85 million Series C funding round led by Accel and Peak XV. The funding is a significant strategic move, aimed at consolidating Truemeds' position in the health-tech market. The acquisition will allow Truemeds to expand its product offerings and reach a wider customer base. The move is a significant step towards a more efficient and less intrusive regulatory environment.